Epilepsy in women

American Family Physician

Volumn 66, Issue 8, 2002, Pages 1489-1494

  Morrell, Martha J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ESTROGEN; ETIRACETAM; FELBAMATE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; LEVONORGESTREL; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROLACTIN; TESTOSTERONE; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

ACNE; ANOVULATION; ARTICLE; BREAST FEEDING; DISEASE SEVERITY; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG EFFICACY; ENZYME ASSAY; EPILEPSY; EVALUATION; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; HIRSUTISM; HUMAN; INFERTILITY; LIVER DISEASE; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OBESITY; ORAL CONTRACEPTION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PUBERTY; RISK ASSESSMENT; SAFETY; SEIZURE; SEXUAL DYSFUNCTION; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; CONTRACEPTION BEHAVIOR; EPILEPSY; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; PREGNANCY; PREGNANCY COMPLICATIONS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0037109814     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
2. Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. Management issues for women with epilepsy: A review of the literature. Neurology 1998;51:949-56.
3. Morrell MJ. Effects of epilepsy on women's reproductive health. Epilepsia 1998;39(suppl 8):S32-7.
4. Woolley CS, Schwartzkroin PA. Hormonal effects on the brain. Epilepsia 1998;39(suppl 8):S2-8.
5. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J Neurosci 1997;17:1848-59.
6. Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999;40:1402-7.
7. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-8.
8. Herzog AG. Progesterone therapy in women with epilepsy: A 3-year follow-up. Neurology 1999;52: 1917-8.
9. Mattson RH, Cramer JA, Darney PD, Naftolin F. Use of oral contraceptives by women with epilepsy. JAMA 1986;256:238-40.
10. Haukkamaa M. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. Contraception 1986;33: 559-65.
11. Practice parameter: Management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;51:944-8.
12. Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: Social and biologic influences. Epilepsia 1994;35: 750-6.
13. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-3.
14. Morrell MJ, Sarto GE, Shafer PO, Borda EA, Herzog A, Callanan M. Health issues for women with epilepsy: A descriptive survey to assess knowledge and awareness among healthcare providers. J Womens Health Gend Based Med 2000;9:959-65.
15. Murialdo G, Galimberti CA, Magri F, Sampaolo P, Copello F, Gianelli MV, et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997; 20:519-26.
16. Drislane FW, Coleman AE, Schomer DL, Ives J, Levesque LA, Seibel MM, et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44:306-10.
17. Bilo L, Meo R, Valentino R, Buscaino GA, Striano S, Nappi C. Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertil Steril 1991;55:705-11.
18. Murialdo G, Galimberti CA, Gianelli MV, Rollero A, Polleri A, Copello F, et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52-8.
19. Morrell MJ, Flynn KL, Seale CG, Doñe S, Paulson AJ, Flaster ER, et al. Reproductive dysfunction in women with epilepsy: Antiepileptic drug effects on sex-steroid hormones. CNS Spectrums 2001;6:771-86.
20. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-8.
21. Isojarvi JI, Rattya J, Myllyla W, Knip M, Koivunen R, Pakarinen AJ, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-51.
22. Morrell MJ, Guldner GT. Self-reported sexual function and sexual arousability in women with epilepsy. Epilepsia 1996;37:1204-10.
23. Morrell MJ, Sperling MR, Stecker M, Dichter MA. Sexual dysfunction in partial epilepsy: A deficit in physiologic sexual arousal. Neurology 1994;44:243-7.
24. ACOG educational bulletin. Seizure disorders in pregnancy. No. 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1997;56:279-86.
25. Schmidt D, Beck-Mannagetta G, Janz D, Koch S. The effect of pregnancy on the course of epilepsy: a prospective study. In: Janz D, Dam M, Richens A, eds. Epilepsy, Pregnancy, and the Child. New York: Raven Press, 1982:39-49.
26. Yerby MS, Friel PN, McCormick K, Koerner M, Van Allen M, Leavitt AM, et al. Pharmacokinetics of anticonvulsants in pregnancy: Alterations in plasma protein binding. Epilepsy Res 1990;5:223-8.
27. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344: 1132-8.
28. Gaily E, Granstrom ML. Minor anomalies in children of mothers with epilepsy. Neurology 1992; 42(4 suppl 5):128-31.
29. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41(RR-14):1-7.